4//SEC Filing
Peters Jeffrey Stuart 4
Accession 0001125345-24-000079
CIK 0001125345other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 6:07 PM ET
Size
15.7 KB
Accession
0001125345-24-000079
Insider Transaction Report
Form 4
MACROGENICS INCMGNX
Peters Jeffrey Stuart
Senior VP and General Counsel
Transactions
- Exercise/Conversion
Common Stock
2024-04-04$4.82/sh+42,500$204,850→ 51,395 total - Sale
Common Stock
2024-04-04$15.07/sh−42,500$640,475→ 8,895 total - Sale
Common Stock
2024-04-04$15.51/sh−147$2,280→ 8,748 total - Sale
Common Stock
2024-04-04$18.22/sh−3,165$57,666→ 0 total - Sale
Common Stock
2024-04-04$16.38/sh−232$3,800→ 8,516 total - Sale
Common Stock
2024-04-04$17.74/sh−5,351$94,927→ 3,165 total - Exercise/Conversion
Employee stock option (right to buy)
2024-04-04$4.82/sh−42,500$204,850→ 127,500 totalExercise: $4.82Exp: 2033-02-15→ Common Stock (42,500 underlying)
Footnotes (6)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/8/2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $15.07 to $15.94. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]This transaction was executed in multiple trades at prices ranging from $16.01 to $16.58. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]This transaction was executed in multiple trades at prices ranging from $17.05 to $17.99. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]This transaction was executed in multiple trades at prices ranging from $18.00 to $18.84. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F6]12.5% of the shares underlying the grant become exercisable 6 months after the 2/15/2023 date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
Documents
Issuer
MACROGENICS INC
CIK 0001125345
Entity typeother
Related Parties
1- filerCIK 0001706903
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 6:07 PM ET
- Size
- 15.7 KB